Post Content Previous Post Sunil Singhania, Prashant Jain invest in Suven Life preferential issue; stock jumps 12% Next Post Lupin's new drug launch could contribute over 25% of its FY26 earnings, analyst says Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email and website in this browser for the next time I comment.Post Comment
